CME Group Inc.
Bear Case (25th pct.)
-54.6% vs price
Base Case (Median)
-46.2% vs price
Bull Case (75th pct.)
-38.6% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $58.59 | -78.1% | High (40%) |
| PE Comparable | $142.61 | -46.8% | Medium (25%) |
| Growth Trajectory DCF | $221.52 | -17.3% | Medium (20%) |
| Graham Number | $145.57 | -45.7% | High (80%) |
Based on 4 out of 8 methods, CME appears overvalued at the current price of $267.88. The base case fair value of $144.09 implies 46.2% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.